Global Export of Heparin for Therapeutic Use by Country

In 2023, China emerged as the largest exporter of heparin for therapeutic use, with a value approximating 3.51 million kilograms. Brazil and the United States followed, showing robust exports of over 2 million kilograms each. Notably, significant year-on-year export growth was observed in Switzerland, Slovakia, and the United Arab Emirates, indicating expanding market capabilities. Conversely, Germany and Denmark experienced notable declines, suggesting potential challenges. The five-year CAGR suggests steady growth in leading markets like China and Brazil, while some European countries struggle with stagnation or decline.

Future trends to watch include potential shifts in production to countries with increased year-on-year growth such as Slovakia and the UAE, while tracking the potential recovery trajectories in declining markets like Germany and Denmark. Additionally, fluctuations in global demand and regulatory changes could significantly influence export volumes.